BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. D-Amino Acids as a Biomarker in Schizophrenia. Diseases 2022;10:9. [DOI: 10.3390/diseases10010009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasyrova RF, Khasanova AK, Altynbekov KS, Asadullin AR, Markina EA, Gayduk AJ, Shipulin GA, Petrova MM, Shnayder NA. The Role of D-Serine and D-Aspartate in the Pathogenesis and Therapy of Treatment-Resistant Schizophrenia. Nutrients 2022;14. [PMID: 36501171 DOI: 10.3390/nu14235142] [Reference Citation Analysis]
2 Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Matsuda S. A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders. Metabolites 2022;12:1052. [DOI: 10.3390/metabo12111052] [Reference Citation Analysis]
3 Ikeda Y, Taniguchi K, Sawamura H, Tsuji A, Matsuda S. Promising role of D-amino acids in irritable bowel syndrome. World J Gastroenterol 2022; 28(31): 4471-4474 [DOI: 10.3748/wjg.v28.i31.4471] [Reference Citation Analysis]
4 Simić K, Todorović N, Trifunović S, Miladinović Z, Gavrilović A, Jovanović S, Avramović N, Gođevac D, Vujisić L, Tešević V, Tasić L, Mandić B. NMR Metabolomics in Serum Fingerprinting of Schizophrenia Patients in a Serbian Cohort. Metabolites 2022;12:707. [DOI: 10.3390/metabo12080707] [Reference Citation Analysis]
5 de Bartolomeis A, Vellucci L, Austin MC, De Simone G, Barone A. Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics. Biomolecules 2022;12:909. [DOI: 10.3390/biom12070909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Sawamura H, Taniguchi K, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia. Explor Neuroprot Ther 2022. [DOI: 10.37349/ent.2022.00019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]